4//SEC Filing
Wambeke David J. 4
Accession 0001235802-24-000053
CIK 0001401040other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:06 PM ET
Size
6.2 KB
Accession
0001235802-24-000053
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-01+130,000→ 130,000 totalExercise: $2.90Exp: 2034-05-31→ Common Shares (130,000 underlying)
Holdings
- 527,114
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001971798
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:06 PM ET
- Size
- 6.2 KB